Metastatic Squamous Cell Carcinoma: What comes after Checkpoint Inhibition?

被引:0
|
作者
Koechel, A. [1 ]
Ioannis, T. [1 ]
Sanchez-Gonzalez, S. [1 ]
Olivia, S. [1 ]
Eva, A. [1 ]
Meiwes, A. [1 ]
Eigentler, T. [2 ]
Leiter-Stoeppke, U. [2 ]
机构
[1] Hautklin Tubingen, Dermatoonkol, Tubingen, Germany
[2] Univ Hautklin Tubingen, Tubingen, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P120
引用
收藏
页码:77 / 78
页数:2
相关论文
共 50 条
  • [31] Metastatic cervical carcinoma: adenocarcinoma = squamous cell carcinoma?
    Hein, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 117 - 117
  • [32] Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma
    Pestana, Roberto Carmagnani
    Becnel, Melody
    Rubin, Maria Laura
    Torman, Danice K.
    Crespo, James
    Phan, Jack
    Hanna, Ehab
    Bell, Diana
    Glisson, Bonnie S.
    Johnson, Jason M.
    Lee, J. Jack
    Ferrarotto, Renata
    ORAL ONCOLOGY, 2020, 101
  • [33] Hyper Progression of Squamous Cell Carcinoma After Initiation of Immune Checkpoint Inhibitor Therapy
    Soni, S.
    Tosonian, S.
    Perumbeti, A.
    Tsai, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [34] Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition
    Siefker-Radtke, Arlene
    Curti, Brendan
    NATURE REVIEWS UROLOGY, 2018, 15 (02) : 112 - 124
  • [35] Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition
    Arlene Siefker-Radtke
    Brendan Curti
    Nature Reviews Urology, 2018, 15 : 112 - 124
  • [36] Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis
    Schieber, Timothy
    Brunk, Kelly
    Clennon, Anna
    Woolbright, Benjamin L.
    Bantis, Leonidas E.
    Grauer, Dennis
    Cheng, Tiewei
    Abbasi, Saqib
    Wulff-Burchfield, Elizabeth
    Parikh, Rahul
    Li, Haoran
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [37] A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma
    Tsung, Irene
    Worden, Francis P.
    Fontana, Robert J.
    ONCOLOGIST, 2021, 26 (02): : 133 - 138
  • [38] Efficacy and safety of immune checkpoint inhibitors (ICI) for the treatment of metastatic penile squamous cell carcinoma (mPSCC).
    Cheng, Tiewei
    Schieber, Timothy J.
    Clennon, Anna
    Bertken, Katie
    Cai, Sunny Shengyuan
    Wulff-Burchfield, Elizabeth Marie
    Abbasi, Saqib
    Parikh, Rahul Atul
    Li, Haoran
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [39] Targeting c-Met to Improve Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
    Lindner, Andrea Katharina
    Pichler, Martin
    Thurnher, Martin
    Pichler, Renate
    EUROPEAN UROLOGY, 2022, 81 (01) : 1 - 2
  • [40] Immune checkpoint inhibitors in sinonasal squamous cell carcinoma
    Park, Jong Chul
    Faquin, William C.
    Durbeck, Julia
    Faden, Daniel L.
    ORAL ONCOLOGY, 2020, 109